FDA Floats Plan To Streamline New Drug Trials
The U.S. Food and Drug Administration on Monday finalized a process for creation of standardized metrics that can be widely used during clinical trials to gauge the safety and effectiveness of...To view the full article, register now.
Already a subscriber? Click here to view full article